The Evidence for Antimuscarinic Agents in Female Mixed Urinary Incontinence

Research output: Contribution to journalArticlepeer-review


Antimuscarinic agents are the most commonly used treatments for overactive bladder (OAB) syndrome where they reduce urgency, frequency, and urge incontinence. Despite few studies investigating the effects of antimuscarinic agents on mixed urinary incontinence (MUI), awareness is increasing about their value as first-line treatments for patients with MUI (combination of OAB wet and stress urinary incontinence). Evidence suggests that they are as effective in patients with urgency-predominant MUI as they are in OAB, resulting in significant reductions in urgency episodes, urinary frequency, and incontinence.

Original languageEnglish
Pages (from-to)849-853
Number of pages5
JournalEuropean Urology, Supplements
Issue number16
Publication statusPublished - Oct 2006


  • Antimuscarinic agents
  • Overactive bladder syndrome (OAB)
  • Solifenacin
  • Stress incontinence
  • Tolterodine

ASJC Scopus subject areas

  • Urology


Dive into the research topics of 'The Evidence for Antimuscarinic Agents in Female Mixed Urinary Incontinence'. Together they form a unique fingerprint.

Cite this